Anticoagulation remains underused in prevention of stroke associated with atrial fibrillation: Insights from two consecutive national surveys

International Journal of Cardiology

Volumn 152, Issue 3, 2011, Pages 356-361

  Schwammenthal, Yvonne ^a   Bornstein, Nathan M ^a   Goldbourt, Uri ^a   Koton, Silvia ^a   Schwartz, Roseline ^a   Koren Morag, Nina ^a   Grossman, Ehud ^a   Tanne, David ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anticoagulation; Atrial fibrillation; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HEPARIN; WARFARIN;

ACUTE DISEASE; AGED; AGING; ANTICOAGULATION; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; COHORT STUDIES; DATA COLLECTION; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; ISRAEL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE;

EID: 80055035465     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.08.005     Document Type: Article

References (38)

1. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
2. M. Lamassa, A. Di Carlo, and G. Pracucci Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project) Stroke 32 2001 392 398
3. R. Saxena, and P.J. Koudstaal Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack Cochrane Database Syst Rev 2004 CD000185
4. K. Kimura, K. Minematsu, and T. Yamaguchi Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke J Neurol Neurosurg Psychiatry 76 2005 679 683
5. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 2007 857 867
6. E.M. Hylek, A.S. Go, and Y. Chang Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation N Engl J Med 349 2003 1019 1026
7. M. O'Donnell, W. Oczkowski, and J. Fang Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study Lancet Neurol 5 2006 749 754
8. K.K. Andersen, and T.S. Olsen Reduced poststroke mortality in patients with stroke and atrial fibrillation treated with anticoagulants: results from a Danish quality-control registry of 22,179 patients with ischemic stroke Stroke 38 2007 259 263 [ http://www.ncbi.nlm.nih.gov/pubmed/17194876 ]
9. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation Jama 285 2001 2864 2870
10. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace 8 2006 651 745
11. L.B. Goldstein, R. Adams, and M.J. Alberts Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline Stroke 37 2006 1583 1633
12. D. Tanne, U. Goldbourt, and S. Koton A national survey of acute cerebrovascular disease in Israel: burden, management, outcome and adherence to guidelines Isr Med Assoc J 8 2006 3 7
13. J. Bamford, P. Sandercock, M. Dennis, J. Burn, and C. Warlow Classification and natural history of clinically identifiable subtypes of cerebral infarction Lancet 337 1991 1521 1526
14. H.P. Adams Jr., B.H. Bendixen, and L.J. Kappelle Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment Stroke 24 1993 35 41
15. B.F. Gage, C. van Walraven, and L. Pearce Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin Circulation 110 2004 2287 2292
16. SAS Institute Inc. SAS/STAT user's guide, version 6, fourth edition. Vol. 1, 1987:943.
17. P.J. Devereaux, D.R. Anderson, and M.J. Gardner Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Bmj 323 2001 1218 1222
18. B.F. Gage, M. Boechler, and A.L. Doggette Adverse outcomes and predictors of underuse of antithrombotic therapy in Medicare beneficiaries with chronic atrial fibrillation Stroke 31 2000 822 827
19. A.S. Go, E.M. Hylek, L.H. Borowsky, K.A. Phillips, J.V. Selby, and D.E. Singer Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study Ann Intern Med 131 1999 927 934
20. N. Cohen, D. Almoznino-Sarafian, and I. Alon Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission Stroke 31 2000 1217 1222
21. A.L. Waldo, R.C. Becker, V.F. Tapson, and K.J. Colgan Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation J Am Coll Cardiol 46 2005 1729 1736
22. D.J. Gladstone, E. Bui, and J. Fang Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated Stroke 40 2009 235 240 [ http://www.ncbi.nlm.nih.gov/pubmed/ 18757287 ]
23. C. Weimar, J. Benemann, Z. Katsarava, R. Weber, and H.C. Diener Adherence and quality of oral anticoagulation in cerebrovascular disease patients with atrial fibrillation Eur Neurol 60 2008 142 148
24. V.F. Tapson, T.M. Hyers, and A.L. Waldo Antithrombotic therapy practices in US hospitals in an era of practice guidelines Arch Intern Med 165 2005 1458 1464
25. R. Leckey, E.G. Aguilar, and S.J. Phillips Atrial fibrillation and the use of warfarin in patients admitted to an acute stroke unit Can J Cardiol 16 2000 481 485
26. S. Nagpal, D. Anderson, W. Putnam, G. Flowerdew, M. Gardner, and J. Cox Stroke prevention in hospitalized patients with atrial fibrillation: a population-based study Can J Clin Pharmacol 10 2003 197 201
27. S. Levy, M. Maarek, and P. Coumel Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists Circulation 99 1999 3028 3035
28. D.E. Singer, G.W. Albers, and J.E. Dalen Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 2008 546S 592S
29. E.M. Hylek, C. Evans-Molina, C. Shea, L.E. Henault, and S. Regan Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 115 2007 2689 2696
30. M.C. Fang, A.S. Go, and Y. Chang Death and disability from warfarin-associated intracranial and extracranial hemorrhages Am J Med 120 2007 700 705
31. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. The European Atrial Fibrillation Trial Study Group N Engl J Med 333 1995 5 10
32. J. Mant, F.D. Hobbs, and K. Fletcher Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503
33. G. Palareti, N. Leali, and S. Coccheri Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy Lancet 348 1996 423 428
34. H. Arima, R.G. Hart, and S. Colman Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack Stroke 36 2005 2164 2169
35. R.G. Hart, O. Benavente, and L.A. Pearce Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: a meta-analysis and hypothesis Cerebrovasc Dis 9 1999 215 217
36. E.M. Hylek, H. Heiman, S.J. Skates, M.A. Sheehan, and D.E. Singer Acetaminophen and other risk factors for excessive warfarin anticoagulation Jama 279 1998 657 662
37. K.A. LaBresh, A.G. Ellrodt, R. Gliklich, J. Liljestrand, and R. Peto Get with the guidelines for cardiovascular secondary prevention: pilot results Arch Intern Med 164 2004 203 209
38. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150